Recombinant CTLA4 (Quavonlimab Biosimilar) anticorps

N° du produit ABIN7829105

L’anticorps anti-CTLA4 (Quavonlimab Biosimilar) Monoclonal Humanized est utilisé pour la détection de CTLA4 (Quavonlimab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant CTLA4 (Quavonlimab Biosimilar) anticorps (ABIN7829105)

Antigène: CTLA4 (Quavonlimab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CTLA4 (Quavonlimab Biosimilar) est non-conjugé

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-CTLA4 (Quavonlimab Biosimilar) anticorps

Fonction: Anti-CTLA-4(quavonlimab biosimilar) mAb

Isotype: IgG1

Information d'application

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur CTLA4 (Quavonlimab Biosimilar)

Antigène: CTLA4 (Quavonlimab Biosimilar)

Autre désignation: Quavonlimab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:CD,GSE,GRD4,ALPS5,CD152,CTLA-4,IDDM12,CELIAC3
Synonyms Antibody:AK-107,MK-1308,AK107,MK1308,AK 107,MK 1308

UniProt: P16410